Edition:
United Kingdom

Healios KK (4593.T)

4593.T on Tokyo Stock Exchange

1,489JPY
24 Nov 2017
Change (% chg)

¥-11 (-0.73%)
Prev Close
¥1,500
Open
¥1,490
Day's High
¥1,510
Day's Low
¥1,485
Volume
126,000
Avg. Vol
87,618
52-wk High
¥2,196
52-wk Low
¥1,345

Summary

Name Age Since Current Position

Tadanao Kagimoto

38 2012 President, Representative Director

Kyoko Takahashi

Executive Officer, Director of Finance & Accounting

Masanori Sawada

33 2015 Managing Director, Director of Business Development

Yoshinari Matsuda

36 2014 Executive Director

Ken Ishikawa

36 2017 Executive Officer, Director

Koichi Tamura

58 2015 Executive Officer, Director of Production, Director

Al Reaves

69 2014 Director of Global Development, Director

Michael Alfant

53 2013 Independent Director

Michihisa Nishiyama

67 2014 Independent Director

Biographies

Name Description

Tadanao Kagimoto

Mr. Tadanao Kagimoto has been serving as President and Representative Director in Healios K.K. since February 2012. He is also serving as President and Representative Director in an associated company and other two companies.

Kyoko Takahashi

Masanori Sawada

Mr. Masanori Sawada has been serving as Managing Director and Director of Business Development in Healios K.K. since March 2015. He joined the Company in April 2012.

Yoshinari Matsuda

Mr. Yoshinari Matsuda has been serving as Executive Director in Healios K.K. since January 2014. He is also in charge of Administration of the Company. He is also serving as Independent Director in Nippon Commercial Development Co., Ltd., and working for Haruyama Trading Co., Ltd. and Uruma Law Offices Legal Professional Corporation.

Ken Ishikawa

Mr. Ken Ishikawa was named Executive Officer and Director in Healios K.K. effective March 24, 2017. He joined the Company in September 2013. He previously served as Director of Human Resources & General Affairs in the Company. He used to work for Accenture Japan Ltd., M-OUT Inc., Rakuten, Inc. and Cookpad Inc.

Koichi Tamura

Mr. Koichi Tamura has been serving as Executive Officer, Director of Production and Director in Healios K.K. since March 2015. He joined the Company in October 2014. He used to work for other four companies.

Al Reaves

Mr. Al Reaves has been serving as Director of Global Development and Director in Healios K.K. since January 2014. He is also serving as President in OphthaConsult, LLC. He used to work for Alcon Laboratories, Inc., Xenon Vision, Inc., Novartis Ophthalmics, Neurotech USA, Inc., Othera Pharmaceuticals, Inc. and Acucela, Inc.

Michael Alfant

Mr. Michael Alfant has been serving as Independent Director in Healios K.K. since January 2013. He is also serving as Director in NewPort Co., Ltd., as well as Group Chairman of the Board and Chief Executive Officer in another company. He used to work for Fusion Systems Group, Fusion Systems and another company.

Michihisa Nishiyama

Mr. Michihisa Nishiyama has been serving as Independent Director in Healios K.K. since June 2014. He used to work for other two companies.